+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Continuous Subcutaneous Insulin Infusion Market - Global Forecast to 2030- Product Image
Continuous Subcutaneous Insulin Infusion Market - Global Forecast to 2030- Product Image
Sale

Continuous Subcutaneous Insulin Infusion Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337448
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Continuous Subcutaneous Insulin Infusion Market grew from USD 3.05 billion in 2024 to USD 3.43 billion in 2025. It is expected to continue growing at a CAGR of 12.20%, reaching USD 6.09 billion by 2030.

Continuous Subcutaneous Insulin Infusion (CSII) represents a pivotal advancement in diabetes management, offering precise, automated insulin delivery that aligns with patients’ dynamic glucose profiles. As healthcare systems worldwide grapple with rising chronic disease burdens, CSII has emerged as an essential tool for enhancing glycemic control, reducing complications, and improving quality of life. This executive summary synthesizes the major developments shaping the CSII landscape, highlights critical segmentation and regional patterns, and identifies leading innovators driving technological progress. By distilling complex trends into actionable insights, it equips decision-makers with the clarity needed to navigate evolving market dynamics and optimize strategic priorities.

Transformative Shifts Redefining the CSII Landscape

In recent years, several transformative shifts have redefined the CSII landscape. The convergence of sensor-augmented pump therapy with advanced algorithmic controls has elevated closed-loop systems from concept to reality, enabling real-time adjustments that more closely mimic pancreatic function. Digital health integration, including Bluetooth connectivity and smartphone applications, has facilitated seamless data sharing between patients and care teams, fostering proactive interventions and personalized care plans. Additionally, the surge in telemedicine adoption has accelerated remote monitoring capabilities, allowing clinicians to optimize insulin regimens without in-person visits. On the clinical front, emerging studies underscore the value of rapid-acting insulin formulations paired with tubeless and disposable infusion platforms to reduce device burden and enhance adherence among diverse age groups. Finally, the growing emphasis on patient-centric design has spurred customizable dosing features and user interface simplicities-such as touchscreen operation-that lower barriers to device adoption and support self-management across all demographic segments.

Cumulative Impact of United States Tariffs 2025

The introduction of United States tariffs on insulin pumps and related components for 2025 has created both challenges and opportunities for suppliers and providers. Manufacturers sourcing components from overseas have faced increased input costs, prompting supply chain realignments toward regional manufacturing hubs. Insulin reservoir and infusion set producers have responded by negotiating long-term contracts with domestic suppliers to mitigate tariff impacts and maintain competitive pricing. Some pump brands have absorbed added costs through leaner operational structures, while others have introduced tiered pricing strategies to shield end users from sudden price hikes. Concurrently, healthcare payers and integrated delivery networks have intensified reimbursement negotiations, seeking value-based agreements that reflect clinical outcomes rather than volume. Although price pressures persist, this policy shift has accelerated efforts to localize production, streamline logistics, and foster strategic partnerships across the ecosystem.

Key Segmentation Insights

Detailed analysis across device type reveals growing traction for tubeless patch pumps that combine compact form factors with advanced dosing algorithms, while connected smart insulin pens-whether Bluetooth enabled or operating offline-gain momentum in patient populations seeking simplicity and data integration. Traditional pumps equipped with disposable cartridge systems maintain a loyal user base, especially among individuals requiring precise basal-bolus customization. From a product perspective, infusion sets-whether flexible cannula or metal cannula-serve as critical accessories, complemented by reservoirs engineered for leak-proof performance. Insulin formulations span intermediate-acting to rapid-acting options, allowing clinicians to tailor regimens according to glycemic targets and lifestyle demands. Usage frequency segmentation underscores the distinction between daily and weekly infusion models, with weekly platforms emerging in niche research phases. End-user analysis indicates that adults living with type 1 diabetes, elderly users managing type 2 diabetes, and pediatric patients all benefit from technology integration, whether through smartphone connectivity or Bluetooth-enabled automation. Service models range from one-time direct purchase offerings to subscription-based programs that bundle supplies and remote support. The market accommodates both economic and premium brands, while innovation pathways focus on artificial intelligence integration and customizable dosing modules. Finally, distribution channels span hospital pharmacies, online pharmacies, and retail outlets-both chain and independent-supported by robust training, support availability, and user interfaces that leverage either button-operated or touchscreen simplicity.

Key Regional Insights

Regional dynamics in the Americas continue to be shaped by strong private-payer ecosystems, broad reimbursement frameworks, and high technology adoption rates, particularly in urban centers. In Europe, Middle East & Africa, regulatory harmonization efforts under the EU Medical Device Regulation and expanding public-sector programs in the Middle East drive uptake, while supply chain resilience remains a priority across Africa. In Asia-Pacific, diverse healthcare infrastructures from advanced economies in Japan and Australia to emerging markets in Southeast Asia create a mosaic of opportunity: established channels in hospital settings coexist with rapid growth in online pharmacy distribution, and government initiatives to expand diabetes care access are fueling long-term demand for CSII solutions.

Key Companies Insights

Global innovation in CSII is led by a varied roster of companies delivering distinct strategic propositions. B. Braun Melsungen AG focuses on modular infusion platforms that integrate with continuous glucose monitoring systems. Becton, Dickinson and Company emphasizes precision engineering in infusion sets and reservoir design to minimize occlusion risk. Bigfoot Biomedical, Inc. pioneers simplified closed-loop kits that retrofit existing pumps with automated dosing technology. CeQur Corporation differentiates through patch pump systems optimized for pediatric and adolescent adherence. Fresenius SE & Co. KGaA leverages its global manufacturing footprint to offer scalable pump solutions under stringent quality controls. MannKind Corporation champions inhalable insulin adjuncts that complement pump therapy and reduce reliance on prefilled cartridges. Medtronic PLC advances algorithmic insulin delivery with its MiniMed series, renowned for integrated sensor analytics. MicroPort Scientific Corporation brings cost-effective pump designs to emerging markets. Nipro Corporation combines catheter innovations with slim form factors to enhance patient comfort. Sanofi S.A. extends its insulin portfolio with pump-compatible formulations. Shinmyung Mediyes CO., LTD. focuses on localizing production for the Korean market. Smiths Group PLC invests in next-generation connectivity protocols. SOOIL Developments Co., Ltd. leads in patch pump miniaturization. Tandem Diabetes Care, Inc. prioritizes user experience through intuitive touchscreen interfaces. Ypsomed AG pushes the frontier of personalized therapy with AI-driven dosing recommendations.

Actionable Recommendations for Industry Leaders

To stay ahead in this rapidly evolving market, industry leaders should prioritize several strategic initiatives. First, deepening collaboration with domestic suppliers can mitigate future tariff disruptions and strengthen supply chain resilience. Second, investing in interoperable digital ecosystems-linking pumps, sensors, and mobile platforms-will drive superior clinical outcomes and support value-based care models. Third, expanding subscription-based service offerings that bundle devices, consumables, and remote coaching can foster customer loyalty and predictable revenue streams. Fourth, accelerating innovation in AI-enabled dosing algorithms and customizable user interfaces will differentiate product portfolios in crowded markets. Fifth, forging strategic partnerships with payers and government programs can streamline reimbursement pathways and broaden access in underserved regions. Finally, implementing continuous feedback loops with patients and clinicians will guide iterative product enhancements, ensuring solutions remain aligned with real-world needs.

Conclusion and Future Outlook

Continuous Subcutaneous Insulin Infusion has transitioned from niche technology to standard-of-care in many diabetes management protocols, driven by advances in automation, connectivity, and patient-centered design. Despite recent policy shifts, including the 2025 tariffs, the market exhibits resilience through supply chain diversification and value-based partnerships. Segmentation and regional insights highlight clear opportunities for tailored offerings that address distinct patient cohorts and reimbursement environments. By embracing digital integration, reinforcing operational agility, and maintaining a relentless focus on clinical outcomes, stakeholders can deliver meaningful improvements in patient quality of life while sustaining competitive differentiation.

Market Segmentation & Coverage

This research report categorizes the Continuous Subcutaneous Insulin Infusion Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Patch Pumps
    • Tubeless
  • Smart Insulin Pens
    • Connected
    • Non-Connected
  • Traditional Pumps
    • Disposable Cartridge
  • Accessories
    • Infusion Sets
      • Flexible Cannula
      • Metal Cannula
    • Reservoirs
  • Insulin
    • Intermediate-Acting
    • Long-Acting
    • Rapid-Acting
  • Daily Use
  • Weekly Use
  • Adults
    • Type 1 Diabetes
  • Elderly
    • Type 2 Diabetes
  • Pediatric
    • Type 1 Diabetes
  • Bluetooth Enabled
  • Smartphone Connected
  • Direct Purchase
  • Subscription
  • Economic
  • Premium
  • Artificial Intelligence Integration
  • Customizable Dosing
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
    • Chain Pharmacies
    • Independent Pharmacies
  • Customization Options
  • Training and Support Availability
  • User Interface Simplicity
    • Button Operated
    • Touchscreen

This research report categorizes the Continuous Subcutaneous Insulin Infusion Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Continuous Subcutaneous Insulin Infusion Market to delves into recent significant developments and analyze trends in each of the following companies:

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Bigfoot Biomedical, Inc.
  • CeQur Corporation
  • Fresenius SE & Co. KGaA
  • MannKind Corporation
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Sanofi S.A.
  • Shinmyung Mediyes CO., LTD.
  • Smiths Group PLC
  • SOOIL Developments Co., Ltd.
  • Tandem Diabetes Care, Inc.
  • Ypsomed AG

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Continuous Subcutaneous Insulin Infusion Market, by Device Type
8.1. Introduction
8.2. Patch Pumps
8.2.1. Tubeless
8.3. Smart Insulin Pens
8.3.1. Connected
8.3.2. Non-Connected
8.4. Traditional Pumps
8.4.1. Disposable Cartridge
9. Continuous Subcutaneous Insulin Infusion Market, by Product Type
9.1. Introduction
9.2. Accessories
9.2.1. Infusion Sets
9.2.1.1. Flexible Cannula
9.2.1.2. Metal Cannula
9.2.2. Reservoirs
9.3. Insulin
9.3.1. Intermediate-Acting
9.3.2. Long-Acting
9.3.3. Rapid-Acting
10. Continuous Subcutaneous Insulin Infusion Market, by Usage Frequency
10.1. Introduction
10.2. Daily Use
10.3. Weekly Use
11. Continuous Subcutaneous Insulin Infusion Market, by End-User
11.1. Introduction
11.2. Adults
11.2.1. Type 1 Diabetes
11.3. Elderly
11.3.1. Type 2 Diabetes
11.4. Pediatric
11.4.1. Type 1 Diabetes
12. Continuous Subcutaneous Insulin Infusion Market, by Technology Integration
12.1. Introduction
12.2. Bluetooth Enabled
12.3. Smartphone Connected
13. Continuous Subcutaneous Insulin Infusion Market, by Service Model
13.1. Introduction
13.2. Direct Purchase
13.3. Subscription
14. Continuous Subcutaneous Insulin Infusion Market, by Brand Type
14.1. Introduction
14.2. Economic
14.3. Premium
15. Continuous Subcutaneous Insulin Infusion Market, by Innovation
15.1. Introduction
15.2. Artificial Intelligence Integration
15.3. Customizable Dosing
16. Continuous Subcutaneous Insulin Infusion Market, by Distribution Channel
16.1. Introduction
16.2. Hospital Pharmacies
16.3. Online Pharmacies
16.4. Retail Pharmacies
16.4.1. Chain Pharmacies
16.4.2. Independent Pharmacies
17. Continuous Subcutaneous Insulin Infusion Market, by User Experience
17.1. Introduction
17.2. Customization Options
17.3. Training and Support Availability
17.4. User Interface Simplicity
17.4.1. Button Operated
17.4.2. Touchscreen
18. Americas Continuous Subcutaneous Insulin Infusion Market
18.1. Introduction
18.2. Argentina
18.3. Brazil
18.4. Canada
18.5. Mexico
18.6. United States
19. Asia-Pacific Continuous Subcutaneous Insulin Infusion Market
19.1. Introduction
19.2. Australia
19.3. China
19.4. India
19.5. Indonesia
19.6. Japan
19.7. Malaysia
19.8. Philippines
19.9. Singapore
19.10. South Korea
19.11. Taiwan
19.12. Thailand
19.13. Vietnam
20. Europe, Middle East & Africa Continuous Subcutaneous Insulin Infusion Market
20.1. Introduction
20.2. Denmark
20.3. Egypt
20.4. Finland
20.5. France
20.6. Germany
20.7. Israel
20.8. Italy
20.9. Netherlands
20.10. Nigeria
20.11. Norway
20.12. Poland
20.13. Qatar
20.14. Russia
20.15. Saudi Arabia
20.16. South Africa
20.17. Spain
20.18. Sweden
20.19. Switzerland
20.20. Turkey
20.21. United Arab Emirates
20.22. United Kingdom
21. Competitive Landscape
21.1. Market Share Analysis, 2024
21.2. FPNV Positioning Matrix, 2024
21.3. Competitive Analysis
21.3.1. B. Braun Melsungen AG
21.3.2. Becton, Dickinson and Company
21.3.3. Bigfoot Biomedical, Inc.
21.3.4. CeQur Corporation
21.3.5. Fresenius SE & Co. KGaA
21.3.6. MannKind Corporation
21.3.7. Medtronic PLC
21.3.8. MicroPort Scientific Corporation
21.3.9. Nipro Corporation
21.3.10. Sanofi S.A.
21.3.11. Shinmyung Mediyes CO., LTD.
21.3.12. Smiths Group PLC
21.3.13. SOOIL Developments Co., Ltd.
21.3.14. Tandem Diabetes Care, Inc.
21.3.15. Ypsomed AG
22. ResearchAI
23. ResearchStatistics
24. ResearchContacts
25. ResearchArticles
26. Appendix
List of Figures
FIGURE 1. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET MULTI-CURRENCY
FIGURE 2. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET MULTI-LANGUAGE
FIGURE 3. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USAGE FREQUENCY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USAGE FREQUENCY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SERVICE MODEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SERVICE MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BRAND TYPE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BRAND TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INNOVATION, 2024 VS 2030 (%)
FIGURE 22. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INNOVATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 24. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER EXPERIENCE, 2024 VS 2030 (%)
FIGURE 26. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER EXPERIENCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 30. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 36. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TUBELESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SMART INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONNECTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY NON-CONNECTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SMART INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TRADITIONAL PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISPOSABLE CARTRIDGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TRADITIONAL PUMPS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INFUSION SETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY FLEXIBLE CANNULA, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY METAL CANNULA, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INFUSION SETS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RESERVOIRS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INTERMEDIATE-ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY LONG-ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RAPID-ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DAILY USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY WEEKLY USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BLUETOOTH ENABLED, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SMARTPHONE CONNECTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DIRECT PURCHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SUBSCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ECONOMIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PREMIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INNOVATION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ARTIFICIAL INTELLIGENCE INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CUSTOMIZABLE DOSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CUSTOMIZATION OPTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TRAINING AND SUPPORT AVAILABILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER INTERFACE SIMPLICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BUTTON OPERATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TOUCHSCREEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER INTERFACE SIMPLICITY, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SMART INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TRADITIONAL PUMPS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INFUSION SETS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INNOVATION, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER INTERFACE SIMPLICITY, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SMART INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TRADITIONAL PUMPS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INFUSION SETS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INNOVATION, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER INTERFACE SIMPLICITY, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SMART INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TRADITIONAL PUMPS, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INFUSION SETS, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INNOVATION, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER INTERFACE SIMPLICITY, 2018-2030 (USD MILLION)
TABLE 133. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 134. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 135. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SMART INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 136. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TRADITIONAL PUMPS, 2018-2030 (USD MILLION)
TABLE 137. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 139. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INFUSION SETS, 2018-2030 (USD MILLION)
TABLE 140. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 141. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 142. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 144. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 145. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 146. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 147. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 148. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 149. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INNOVATION, 2018-2030 (USD MILLION)
TABLE 150. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 152. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 153. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER INTERFACE SIMPLICITY, 2018-2030 (USD MILLION)
TABLE 154. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 155. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 156. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SMART INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 157. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TRADITIONAL PUMPS, 2018-2030 (USD MILLION)
TABLE 158. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 160. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INFUSION SETS, 2018-2030 (USD MILLION)
TABLE 161. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 162. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 163. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 165. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 166. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 167. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 168. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 169. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 170. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INNOVATION, 2018-2030 (USD MILLION)
TABLE 171. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 173. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 174. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER INTERFACE SIMPLICITY, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SMART INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TRADITIONAL PUMPS, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INFUSION SETS, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INNOVATION, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER INTERFACE SIMPLICITY, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SMART INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TRADITIONAL PUMPS, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INFUSION SETS, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INNOVATION, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER INTERFACE SIMPLICITY, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SMART INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TRADITIONAL PUMPS, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INFUSION SETS, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INNOVATION, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 238. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 239. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER INTERFACE SIMPLICITY, 2018-2030 (USD MILLION)
TABLE 240. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 241. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 242. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SMART INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 243. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TRADITIONAL PUMPS, 2018-2030 (USD MILLION)
TABLE 244. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 246. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INFUSION SETS, 2018-2030 (USD MILLION)
TABLE 247. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 248. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 249. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 250. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 251. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 252. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 253. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 254. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 255. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 256. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INNOVATION, 2018-2030 (USD MILLION)
TABLE 257. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 259. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 260. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER INTERFACE SIMPLICITY, 2018-2030 (USD MILLION)
TABLE 261. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 262. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 263. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SMART INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 264. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TRADITIONAL PUMPS, 2018-2030 (USD MILLION)
TABLE 265. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 267. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INFUSION SETS, 2018-2030 (USD MILLION)
TABLE 268. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 269. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 270. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 271. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 272. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ELDERLY, 2018-2030 (USD MILLION)
TABLE 273. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 274. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 275. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 276. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 277. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INNOVATION, 2018-2030 (USD MILLION)
TABLE 278. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 280. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 281. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY USER INTERFACE SIMPLICITY, 2018-

Companies Mentioned

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Bigfoot Biomedical, Inc.
  • CeQur Corporation
  • Fresenius SE & Co. KGaA
  • MannKind Corporation
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Sanofi S.A.
  • Shinmyung Mediyes CO., LTD.
  • Smiths Group PLC
  • SOOIL Developments Co., Ltd.
  • Tandem Diabetes Care, Inc.
  • Ypsomed AG

Methodology

Loading
LOADING...

Related Topics

Related Reports

Continuous Subcutaneous Insulin Infusion Market Size, Share & Trends Analysis Report By Product, By Patient Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Continuous Subcutaneous Insulin Infusion Market Size, Share & Trends Analysis Report By Product, By Patient Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 110 Pages
  • Global
From
Insulin Patch Pumps Market Report 2025 - Product Image

Insulin Patch Pumps Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Insulin Pumps - Global Strategic Business Report - Product Image

Insulin Pumps - Global Strategic Business Report

  • Report
  • 258 Pages
  • Global
From
Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 216 Pages
  • Global
From
Insulin Infusion Pumps - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Insulin Infusion Pumps - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.